Larimar Therapeutics, Inc.

NasdaqGM:LRMR Stock Report

Market Cap: US$343.2m

Larimar Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:LRMR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
31 Jul 25BuyUS$30,000,000Deerfield Management Company, L.P.Company9,375,000US$3.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of LRMR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders869,6061.02%
VC/PE Firms10,973,39112.8%
General Public12,876,63715%
Institutions30,263,78435.4%
Hedge Funds30,606,97435.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 34.1%.


Top Shareholders

Top 25 shareholders own 79.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
35.8%
Deerfield Management Company, L.P.
30,606,974US$122.7m44.2%2.32%
7.06%
RA Capital Management, L.P.
6,045,351US$24.2m0%0.31%
5.76%
CHI Advisors LLC
4,928,040US$19.8m3.14%12.46%
4.8%
Opaleye Management Inc.
4,110,000US$16.5m115%2.89%
4.27%
Millennium Management LLC
3,655,189US$14.7m443%0.01%
3.55%
BlackRock, Inc.
3,039,980US$12.2m-2.69%no data
2.5%
The Vanguard Group, Inc.
2,142,031US$8.6m-3.42%no data
2.43%
Alyeska Investment Group, L.P.
2,075,882US$8.3m43.9%0.03%
1.56%
Citadel Advisors LLC
1,336,255US$5.4m208%0.01%
1.34%
Two Sigma Advisers, LP
1,146,924US$4.6m191%0.01%
1.06%
Geode Capital Management, LLC
904,425US$3.6m-0.39%no data
1.06%
Two Sigma Investments, LP
903,611US$3.6m129%0.01%
1%
State Street Global Advisors, Inc.
858,968US$3.4m3.17%no data
0.9%
Mangrove Partners IM, LLC
770,233US$3.1m0%0.34%
0.81%
Caption Management, LLC
689,290US$2.8m0%0.25%
0.73%
Woodline Partners LP
622,682US$2.5m0%0.01%
0.69%
Thomas Hamilton
590,811US$2.4m4.61%no data
0.66%
Verition Fund Management LLC
567,683US$2.3m0%0.01%
0.66%
Renaissance Technologies LLC
561,742US$2.3m-42.4%no data
0.63%
Driehaus Capital Management LLC
535,464US$2.1m50.4%0.01%
0.47%
Morgan Stanley, Investment Banking and Brokerage Investments
405,879US$1.6m0%no data
0.43%
Dafna Capital Management, LLC
371,434US$1.5m0%0.41%
0.4%
Northern Trust Global Investments
343,981US$1.4m-5.93%no data
0.36%
UBS O'Connor LLC
307,198US$1.2m70.6%0.11%
0.3%
Assenagon Asset Management S.A.
256,861US$1.0m17.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/17 00:53
End of Day Share Price 2025/08/15 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Larimar Therapeutics, Inc. is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher ChenBaird
null nullBaird
Joel BeattyBaird